InvestorsHub Logo
icon url

olddogwithnewtrix

03/31/11 9:05 PM

#844 RE: biolover #843

Those results are without a statin. With a statin most don't see much(if any) increase, and again, many Drs consider the slight increase to be benign. Remember lovaza did recieve an approvable letter for 200-500 tgs. Again, I think there is some good upside on the stock, but LDL is not black and white. Particle density is what most specialists are concerned about. Epanova's numbers are pretty impressive, if the numbers on the statin patients look good, there will be competition out there. You can think what you want, big pharma is weighing all this stuff. I sounded exactly like you before I really read about particle density etc